Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.65 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3687653 | 0.91 | HIF1A (0.66) | HIF1AMAOAMAOBOPRL1MAPT | |
| SCHEMBL3696550 | 0.91 | HIF1A (0.52) | HIF1AMAOAMAOBOPRL1MAPT | |
| SCHEMBL3696553 | 0.91 | HIF1A (0.52) | HIF1AMAOAMAOBOPRL1MAPT | |
| SCHEMBL3752978 | 0.84 | HIF1A (0.63) | HIF1AMAPT | |
| SCHEMBL3759608 | 0.83 | HIF1A (0.76) | HIF1A | |
| SCHEMBL3689830 | 0.83 | HIF1A (0.42) | HIF1AMAOAMAOBOPRL1MAPT | |
| SCHEMBL3686580 | 0.82 | HIF1A (0.53) | HIF1AMAOAMAOBOPRL1MAPT | |
| SCHEMBL5076404 | 0.82 | HIF1A (0.58) | HIF1AMAOAMAOBMAPTSMN1; SMN2 | |
| SCHEMBL3686581 | 0.82 | HIF1A (0.53) | HIF1AMAOAMAOBOPRL1MAPT | |
| SCHEMBL3692328 | 0.82 | HIF1A (0.55) | HIF1AOPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231591-B1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORP (KR) | 2015-02-11 | — | — | EP | claimed |
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | claimed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | claimed |
| EP-2231591-A2 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | Kyung Nong Corporation (KR) | 2010-09-29 | — | — | EP | claimed |
| WO-2009072837-A2 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2009-06-11 | — | — | WO | claimed |
| EP-2231591-B1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORP (KR) | 2015-02-11 | — | — | EP | disclosed |
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | disclosed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | disclosed |
| EP-2231591-A2 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | Kyung Nong Corporation (KR) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009072837-A2 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2009-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | CYP51A1, MSMO1, MTMR1 | HIF1A 3994/4885MAOA 207/4885MAOB 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.